Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).

Pediatr Rheumatol Online J 2019 Apr 11;17(1):15. Epub 2019 Apr 11.

Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.

Background: Although there are many reports on Juvenile Idiopathic arthritis-associated uveitis (JIA-U) from various countries, especially from Europe and North America, there are few reports from Asia. Our aim was to investigate the epidemiology, characteristics and predictors of JIA-U in Japan.

Methods: Data were retrospectively collected on 726 patients with JIA from medical records as of April 2016 at 15 medical centers specialized in pediatric rheumatic diseases. Of these, patients with uveitis were further investigated for the specific characteristics of this manifestation.

Results: The prevalence of uveitis was 6.1% in the 726 JIA patients examined. Incidence of uveitis was significantly higher in patients with an earlier arthritis onset (2.6-vs.-5.8 years, P < 0.0001), oligoarthritis (16.1%-vs.-1.6%, P < 0.001), or anti-nuclear antibodies. On the contrary, it was significantly less common in patients with rheumatoid factor or anti-cyclic citrullinated peptide antibodies. A history of using methotrexate (MTX), infliximab or adalimumab was also associated with uveitis occurrence. The median age at uveitis diagnosis was 5 years, and the median time from arthritis onset to uveitis diagnosis was 2 years. The occurrence of anterior and bilateral uveitis was 79.3 and 53.7%, respectively. There were no symptoms at uveitis diagnosis in 58.5% of cases. Complications arising between the time of uveitis diagnosis and the last observation increased from 31.7 to 56.1%; in particular, cataract was increased 3-fold. While no patients lost their vision, 61.9% did not recover normal vision (≥ 1.0), and in many cases active uveitis persisted, especially in males. In addition to steroid eye drops (97.6%) and MTX (15.4%), biological agents were used for treating the uveitis in 41.5% of patients.

Conclusions: The epidemiology, characteristics and predictors of JIA-U in Japan are described here for the first time. Although the prevalence of JIA-U in Japan is lower than in predominantly Caucasian cohorts, as reported from North America and Europe, the epidemiology, characteristics and predictors were found to be similar.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12969-019-0318-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460824PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
17 Reads
1.622 Impact Factor

Publication Analysis

Top Keywords

juvenile idiopathic
8
uveitis
5
medical records
4
records april
4
jia medical
4
patients jia
4
april 2016
4
medical centers
4
pediatric rheumatic
4
specialized pediatric
4
centers specialized
4
726 patients
4
2016 medical
4
patients
4
predictors jia-u
4
characteristics predictors
4
epidemiology characteristics
4
investigate epidemiology
4
jia-u japanmethods
4
data retrospectively
4

References

(Supplied by CrossRef)
Article in Arthritis Rheum
RK Saurenmann et al.
Arthritis Rheum 2007
Article in Rheumatology
A Heiligenhaus et al.
Rheumatology 2007
Article in Clin Exp Rheumatol
K Kotaniemi et al.
Clin Exp Rheumatol 2014
Article in J Rheumatol
ST Angeles-Han et al.
J Rheumatol 2013
Article in Pediatr Rheumatol
E Nordal et al.
Pediatr Rheumatol 2017
Article in PLoS One
HH Yu et al.
PLoS One 2013
Article in Surv Ophthalmol
K Kotaniemi et al.
Surv Ophthalmol 2003
Article in Ocul Immunol Inflamm
AT Berk et al.
Ocul Immunol Inflamm 2001

N Okamoto et al.
2015
Article in Mod Rheumatol
N Okamoto et al.
Mod Rheumatol 2018
Article in J Rheumatol
PE Petty et al.
J Rheumatol 2004

Similar Publications